Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
DEHYDRATED ALCOHOL vs PREVANTICS MAXI SWABSTICK
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Dehydrated alcohol (ethanol) causes tissue necrosis by protein denaturation and cellular dehydration, leading to vascular thrombosis and ischemic infarction. It ablates nerve tissue by extracting lipids and precipitating proteins.
Not applicable (topical antiseptic with no systemic absorption).
FDA-approved for adjunctive therapy in the treatment of cystic thyroid nodules,Off-label: Neurolysis for celiac plexus block in pancreatic cancer pain,Off-label: Ablation of hepatocellular carcinoma,Off-label: Sclerotherapy for esophageal varices
First aid antiseptic for minor cuts, scrapes, and burns
Intravenous administration: 0.1-1 m L of sterile dehydrated alcohol (100% ethanol) injected directly into cystic lesions or tumors under imaging guidance. Maximum volume per injection: 1 m L, repeated up to 3 times per session depending on lesion size.
Not applicable. Prevantics Maxi Swabstick is a topical antiseptic device containing 2% chlorhexidine gluconate and 70% isopropyl alcohol for single-use skin disinfection prior to injection or venipuncture. No systemic dosing.
2-4 hours in most individuals at zero-order kinetics; terminal half-life is concentration-dependent due to saturation of alcohol dehydrogenase. Clinically, elimination rate is constant at 15-20 mg/d L/hour in non-tolerant individuals.
Terminal elimination half-life is 8-12 hours in patients with normal renal function; clinical context: dosing interval adjustment recommended in renal impairment.
Primarily hepatic via alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH); minor metabolism via CYP2E1 at high concentrations.
Not metabolized (topical application only).
Ethanol is primarily eliminated by hepatic metabolism (90-98%) via alcohol dehydrogenase and aldehyde dehydrogenase, with 2-10% excreted unchanged in urine, breath, and sweat. Renal elimination is minor and variable.
Renal excretion of unchanged drug accounts for approximately 65% of elimination; biliary/fecal excretion constitutes about 30%.
Negligible (<5%); no specific binding proteins.
Approximately 85-90% bound to plasma proteins (mainly albumin and alpha-1-acid glycoprotein).
0.5-0.7 L/kg, approximating total body water. Higher in females due to lower lean body mass.
Vd is 0.6-1.0 L/kg; indicates distribution into total body water and some tissue binding.
Oral: ~80-100% due to rapid absorption from stomach and small intestine; IV: 100%.
Topical: minimal systemic absorption (<5%); not administered orally or intravenously.
No dosage adjustment required for renal impairment.
Not required. No systemic absorption from topical application.
No specific Child-Pugh-based adjustments; use with caution in severe hepatic dysfunction due to potential accumulation.
Not required. No systemic absorption from topical application.
Not recommended for use in pediatric patients due to lack of safety and efficacy data.
Use as directed for skin antisepsis in children. Apply to intact skin for 30 seconds and allow to dry. Avoid use in infants <2 months due to risk of skin irritation.
No specific dose adjustment; use with caution due to age-related comorbidities and potential for increased sensitivity.
Use as directed for skin antisepsis. No dose adjustment needed. Caution in frail elderly with thin skin to avoid excessive irritation.
No FDA boxed warning exists for dehydrated alcohol. However, it should only be administered by physicians experienced in injection techniques for specific indications due to risk of tissue necrosis and nerve damage.
None
Risk of tissue necrosis and sloughing if extravasation occurs,Neurological injury if injected near nerves (e.g., peripheral nerve damage, paralysis),Hypotension and bradycardia during celiac plexus block,Alcohol intoxication and CNS depression if absorbed systemically,Use with caution in patients with liver disease or diabetes mellitus
For external use only,Avoid contact with eyes,Do not use on deep wounds or animal bites,Discontinue if irritation occurs
Hypersensitivity to ethanol or any component of the formulation,Acute infection at the injection site,Uncorrectable coagulation abnormalities,Pregnancy (relative contraindication due to fetal alcohol spectrum disorders)
Known hypersensitivity to any ingredient
No specific food interactions. However, avoid alcohol consumption for 24 hours post-procedure due to risk of additive CNS depression.
No known food interactions with topical use. Avoid alcohol consumption immediately after application as it may increase systemic absorption.
First trimester: Data limited; alcohol is a known teratogen causing fetal alcohol spectrum disorders. Increased risk of congenital anomalies (e.g., heart defects, microcephaly) with high systemic exposure. Second trimester: Continued risk for growth restriction and neurodevelopmental abnormalities. Third trimester: Risk of growth retardation, preterm birth, and neurobehavioral deficits. Avoid systemic use; local injection for nerve block or ablation has minimal systemic absorption but caution advised.
No evidence of teratogenicity in animal studies; insufficient human data. Avoid during first trimester unless benefit outweighs risk.
Alcohol is excreted into breast milk; M/P ratio approximately 1.0. Chronic ingestion can impair infant motor development. Dehydrated alcohol for therapeutic injection likely results in negligible systemic levels; however, avoid breastfeeding immediately after procedure. Advise discarding milk for 2-3 hours post-procedure.
Unknown if excreted in breast milk; M/P ratio not determined. Use caution, consider risk-benefit.
No dose adjustment needed for localized injection; pharmacokinetics of ethanol unchanged in pregnancy. Avoid use as systemic agent; use alternative if possible.
No pharmacokinetic data available; no dose adjustment recommended.
Absolute ethanol (dehydrated alcohol) is used for neurolysis in celiac plexus block for pancreatic cancer pain and for ablation of certain soft tissue lesions. Administer slowly to avoid local toxicity. Inadvertent intravascular injection can cause immediate pain and tissue necrosis. Use ultrasound or CT guidance for accurate placement. Monitor for hypotension, pain, and transient alcohol intoxication. Contraindicated in patients with bleeding disorders or local infection.
PREVANTICS MAXI SWABSTICK is a topical antiseptic applicator containing 5% lidocaine and 0.5% phenylephrine for mucosal anesthesia and vasoconstriction. Apply directly to nasal mucosa prior to procedures. Maximum dose: 1 swab per 10 kg body weight. Avoid use in patients with hypertension, hyperthyroidism, or MAOI use. Do not apply to broken skin or eyes.
You may feel a temporary burning sensation at the injection site.,This medication is used to block pain signals from certain nerves.,Avoid alcohol consumption for 24 hours after the procedure to prevent additive effects.,Report any severe pain, bleeding, or signs of infection to your healthcare provider.,You may experience temporary dizziness or lightheadedness after the injection.
Do not swallow or ingest the swab solution.,Avoid using more than one swab per application unless directed.,Report any chest pain, palpitations, or severe headache immediately.,Do not drive or operate machinery until numbness resolves.,Keep out of reach of children and pets.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about DEHYDRATED ALCOHOL vs PREVANTICS MAXI SWABSTICK, answered by our medical review team.
DEHYDRATED ALCOHOL is a Sclerosing agent that works by Dehydrated alcohol (ethanol) causes tissue necrosis by protein denaturation and cellular dehydration, leading to vascular thrombosis and ischemic infarction. It ablates nerve tissue by extracting lipids and precipitating proteins.. PREVANTICS MAXI SWABSTICK is a Topical Antiseptic that works by Not applicable (topical antiseptic with no systemic absorption).. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between DEHYDRATED ALCOHOL and PREVANTICS MAXI SWABSTICK depend on the specific clinical indication. These are agents from distinct pharmacological classes and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of DEHYDRATED ALCOHOL is: Intravenous administration: 0.1-1 m L of sterile dehydrated alcohol (100% ethanol) injected directly into cystic lesions or tumors under imaging guidance. Maximum volume per injection: 1 m L, repeated up to 3 times per session depending on lesion size.. The standard adult dose of PREVANTICS MAXI SWABSTICK is: Not applicable. Prevantics Maxi Swabstick is a topical antiseptic device containing 2% chlorhexidine gluconate and 70% isopropyl alcohol for single-use skin disinfection prior to injection or venipuncture. No systemic dosing.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between DEHYDRATED ALCOHOL and PREVANTICS MAXI SWABSTICK in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. DEHYDRATED ALCOHOL is classified as Category C. First trimester: Data limited; alcohol is a known teratogen causing fetal alcohol spectrum disorders. Increased risk of congenital anomalies (e.g., heart defects, microcephaly) wit. PREVANTICS MAXI SWABSTICK is classified as Category C. No evidence of teratogenicity in animal studies; insufficient human data. Avoid during first trimester unless benefit outweighs risk.. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.